Recruiting × Central Nervous System Neoplasms × 1 year × Clear all PNOC023
Phase 1 Recruiting
208 enrolled
IPAX BrIGHT
Phase 3 Recruiting
50 enrolled
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Phase 1/2 Recruiting
42 enrolled
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Recruiting
200 enrolled
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Phase 2 Recruiting
24 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
Project: Every Child for Younger Patients With Cancer
Recruiting
75,000 enrolled
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
Phase 2 Recruiting
150 enrolled
A Study of Avutometinib for People With Solid Tumor Cancers
Phase 1 Recruiting
23 enrolled
NEMO
Recruiting
600 enrolled
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Recruiting
24 enrolled
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Phase 2 Recruiting
52 enrolled
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Phase NA Recruiting
80 enrolled
ELECTRA
Phase 1/2 Recruiting
73 enrolled
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Recruiting
100 enrolled
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
Phase NA Recruiting
500 enrolled
FUS Etoposide for DMG
Phase 1 Recruiting
10 enrolled
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/2 Recruiting
90 enrolled
iCaRe2
Recruiting
999,999 enrolled
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
Phase 1 Recruiting
48 enrolled
FCBTR
Recruiting
4,000 enrolled
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Phase 1 Recruiting
18 enrolled
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 Recruiting
102 enrolled
Tissue Collection for Drug Screening and Bioanalysis
Recruiting
500 enrolled
KinLET
Phase 1 Recruiting
20 enrolled
Somatic Mosaicism in Twins Discordant for Childhood Cancer
Recruiting
50 enrolled
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Phase 1 Recruiting
90 enrolled
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Recruiting
250 enrolled
DOMINO-START
Phase 4 Recruiting
200 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/2 Recruiting
65 enrolled
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
Recruiting
120 enrolled
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Recruiting
2,500 enrolled
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Phase 1/2 Recruiting
10 enrolled
Brain Slice Explants to Predict Drug Response in Brain Tumors
Recruiting
50 enrolled
CNS Qualitative Interview
Recruiting
20 enrolled
PREMIER
Recruiting
500 enrolled
CA2024-LM-001
Phase 1 Recruiting
24 enrolled
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
Phase 1/2 Recruiting
28 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Recruiting
100 enrolled
DALY II USA/ MB-CART2019.1 for DLBCL
Phase 2 Recruiting
248 enrolled
TRACE
Recruiting
10,000 enrolled
AI-RAD
Recruiting
6,000 enrolled
Cerebrospinal Fluid Biomarkers for Brain Tumors
Recruiting
300 enrolled